Jon Våbenø
Impact in
- Oncology top 10%
- Chemokine receptors and signaling
- Drug Transport and Resistance Mechanisms
- Pharmaceutical Science top 10%
Papers in
- Oncology 20
- Chemokine receptors and signaling 15
- Drug Transport and Resistance Mechanisms 5
-
- Chemical Synthesis and Analysis 6
- vaccines and immunoinformatics approaches 5
- Co-authors
- Mette M. Rosenkilde (14 shared papers)Kristina Luthman (5 shared papers)Tore Lejon (4 shared papers)Stefanie Thiele (4 shared papers)Garland R. Marshall (2 shared papers)Gregory V. Nikiforovich (2 shared papers)Carsten Uhd Nielsen (5 shared papers)Bente Steffansen (5 shared papers)
- Journals
- Journal of Medicinal Chemistry (4 papers)Bioorganic & Medicinal Chemistry (3 papers)FEBS Letters (1 paper)Science Signaling (1 paper)ACS Pharmacology & Translational Science (1 paper)
- Partner nations
- NorwayDenmarkUnited States
In The Last Decade
Jon Våbenø
24 papers receiving 441 citations
Peers
Comparison fields: 5 of 78
- Oncology 236
- Pharmaceutical Science 30
- Immunology 96
- Biochemistry 34
- Molecular Biology 233
Countries citing papers authored by Jon Våbenø
This map shows the geographic impact of Jon Våbenø's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Våbenø with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Våbenø more than expected).
Fields of papers citing papers by Jon Våbenø
This network shows the impact of papers produced by Jon Våbenø. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Våbenø. The network helps show where Jon Våbenø may publish in the future.
Co-authors
The 25 scholars most cited alongside Jon Våbenø, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 56 | |
| 2 | 2014 | 41 | |
| 3 | 2002 | 40 | |
| 4 | 2004 | 35 | |
| 5 | 2021 | 35 | |
| 6 | 2004 | 32 | |
| 7 | 2003 | 31 | |
| 8 | 2006 | 30 | |
| 9 | 2012 | 24 | |
| 10 | 2006 | 18 | |
| 11 | 2015 | 17 | |
| 12 | 2014 | 14 | |
| 13 | 2013 | 13 | |
| 14 | 2006 | 13 | |
| 15 | 2005 | 13 | |
| 16 | 2018 | 10 | |
| 17 | 2021 | 8 | |
| 18 | 2005 | 8 | |
| 19 | 2022 | 6 | |
| 20 | 2016 | 4 |
About Jon Våbenø
Jon Våbenø is a scholar working on Oncology, Molecular Biology, Immunology, Infectious Diseases and Organic Chemistry, having authored 24 papers that have together received 455 indexed citations. Recurring topics across this work include Chemokine receptors and signaling (15 papers), Chemical Synthesis and Analysis (6 papers), Immunotherapy and Immune Responses (5 papers), Drug Transport and Resistance Mechanisms (5 papers), vaccines and immunoinformatics approaches (5 papers), HIV/AIDS drug development and treatment (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). The work is most often cited by research in Oncology (236 citations), Pharmaceutical Science (30 citations), Immunology (96 citations), Biochemistry (34 citations) and Molecular Biology (233 citations). Jon Våbenø has collaborated with scholars based in Norway, Denmark and United States. Frequent co-authors include Mette M. Rosenkilde, Kristina Luthman, Tore Lejon, Stefanie Thiele, Garland R. Marshall, Gregory V. Nikiforovich, Carsten Uhd Nielsen, Bente Steffansen, Anne Steen and Nicola Realdon. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, FEBS Letters, Science Signaling and ACS Pharmacology & Translational Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.